SlideShare ist ein Scribd-Unternehmen logo
1 von 95
Downloaden Sie, um offline zu lesen
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
 All management systems are focused on
getting the job done.
 More efficient and effective management
guarantees the job to be done in the
proper way.
Larger profit Better serviceVs
STAGE ACTIVITIES PERFORMED
1. TOTAL QUALITY MANAGEMENT Management approach centered around
“Customer Satisfaction”
2. QUALITY MANAGEMENT All of the below plus the economic
aspects of “Cost of Quality”
3. QUALITY SYSTEM “Comprehensive and Coordinated”
efforts to meet quality objectives
4. QUALITY ASSURANCE Systematic activities to provide
“Confidence” that the organization
meets requirements for quality
5. QUALITY CONTROL Operational techniques applied to
“Specific Tasks” for quality and
regulatory compliance.
Quality control lecture CPath master 2014 Ain Shams
 Quality : degree to which a set of inherent characteristics
fulfills requirements
 Quality control: part of quality management focused on
fulfilling quality requirements
 Quality assurance: part of quality management focused
on providing confidence that quality requirements will be
fulfilled
 Quality management: coordinated activities to direct and
control an organization with regard to quality
1942-521942-52 US Military develop requirements for contractors for shell, aircraft, missileUS Military develop requirements for contractors for shell, aircraft, missile
supplierssuppliers (Quality without 100% inspection)(Quality without 100% inspection)
19471947 International Organization for Standardization (ISO)International Organization for Standardization (ISO) created to adopt industrialcreated to adopt industrial
standardsstandards
19591959 US Department of Defense establishedUS Department of Defense established MIL-Q-9858MIL-Q-9858 quality managementquality management
19631963 MIL-Q-9858 is internationalized as anMIL-Q-9858 is internationalized as an ABCAABCA standardstandard
19681968 NATO adopts MIL-Q-9858A as Allied Quality Assurance Publication 1 (NATO adopts MIL-Q-9858A as Allied Quality Assurance Publication 1 (AQAP-1AQAP-1))
19791979 British Standards Institute (BSI) developed AQAP-1 for civilian useBritish Standards Institute (BSI) developed AQAP-1 for civilian use BS 5750BS 5750
 Calibration: the process of testing and
adjustment of an instrument, kit, or test system to
provide a known relationship between the
measurement response and the value of the
substance measured by the test procedure
 Effectiveness: the extent to which planned
activities are realized and planned results
achieved
 Efficiency: the relationship between the results
achieved and the resources used
 Non-QMS processes – processes that are not
contained in either the QSEs or in the laboratory’s
path of workflow, such as those within the finance,
sales, or marketing functions.
 Path of workflow: the sequential processes in a
laboratory’s activities that transform a request for
examination into the laboratory information that is
captured in the report of results.
 Plan: written account of intended future course of
actions aimed at achieving specific goal(s) or
objective(s) within a specific timeframe and explains in
detail what needs to be done, when, how, and by
whom.
Quality control lecture CPath master 2014 Ain Shams
 
Organization
Customer Focus
Facilities and Safety
Personnel
Purchasing and Inventory
Equipment
Process Management
 Pre-examination
Examination
Post-examination
Documents and Records
Information Management
Nonconforming Event Management
Assessments
Continual Improvement
Pree-xamination
Examination
Post-examination
Information Management
 Quality System Essentials -
those elements which must
be applied to all operations
in the service’s path of
workflow
 Path of Workflow - as it
relates to the processes
involved in the pre-, during and
post- phases of delivery of
services with the laboratory as
an example
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
! Internal Quality Control (IQC)
Procedures
! External Quality Assessment
(EQA)
! Quality Management
Internal Quality Control
⇒ Done during daily routine work
⇒ Provides an immediate control
⇒ Errors are corrected immediately
⇒ Routinely collect and analyze data from
every test run or procedure
Why do we need Internal Quality Control?
! Ensure that test results are reliable
(trustable)
! Ensure that test results are reproducible
(Closeness of the results of assays of the
same test carried under changed conditions)
! Control quality of daily routine work
Monitoring quality of laboratory testing,
accuracy and precision of laboratory results
 Precise and
Inaccurate
 Precise and Accurate
 Imprecise and
Inaccurate
 Imprecise and ??
Accurate
 It ensures continual check that the laboratory’s work does not
fluctuate and that reports are validated before they are
released.
 It is based on monitoring the procedures which are actually
used for the tests in the laboratory. It includes:
· Control charts with tests on control materials
· Duplicate tests on all specimens or on a proportion of the
specimens
· Delta check, comparing current test results with previous
results
· Consistency of mean values of patient data
 Use 2-3 levels of controls covering the
medical decision points
 At least 20 control values over a period of
20-30 days for each level of control
 Perform statistical analysis
 Develop Levey-Jenning chart
 Run -regularly- with patient samples
 Monitor control values on chart using
Westgard rules
 Take immediate corrective action, if needed
 Record actions taken (if any)
 QC material must be available in large
quantities stored in small aliquots (Ideally
should last for at least 1 year)
 Always consider as Biohazardous
 Requires very accurate reconstitution if
needed
 Always deal with and store as recommended
by manufacturer
 Need data set of at least 20 points obtained
over 20-30 days better by different operators
in different times of day
 Calculate mean, standard deviation,
Coefficient of variation and determine target
ranges
 Develop Levey-Jenning charts
 Plot –on the chart- control values each run/
day
 Make decisions regarding acceptability of run
using Westgard rules
 Monitor over time and at defined intervals
1. 192 mg/dL
2. 194 mg/dL
3. 196 mg/dL
4. 196 mg/dL
5. 160 mg/dL
6. 196 mg/dL
7. 200 mg/dL
8. 200 mg/dL
9. 202 mg/dL
10. 255 mg/dL
11. 204 mg/dL
12. 208 mg/dL
13. 212 mg/dL
80
85
90
95
100
105
110
115
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Day
Mean
+1SD
+2SD
+3SD
-1SD
-2SD
-3SD
80
85
90
95
100
105
110
115
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Day
Mean
+1SD
+2SD
+3SD
-1SD
-2SD
-3SD
Quality control lecture CPath master 2014 Ain Shams
 Ideally should have control values clustered around
the mean (+/-2 SD) with little variation in the upward
or downward direction
 Imprecision = large amount of scatter around the
mean. Usually caused by errors in technique
 Inaccuracy = may see as a trend or a shift, usually
caused by change in the testing process
 Random error = no pattern. Usually poor technique,
malfunctioning equipment
Random Error (RE):
Imprecision
 Causes:
1. Pipetting error
2. Temperature error
3. Mixing defect
4. Machine need
troubleshooting
 Systematic Error
(SE): Inaccuracy
 Causes:
1. Deterioration of
control material
2. Deterioration of
calibrator
3. Deterioration of
reagents
 Allows determination of whether an analytical
run/s (in control) or (out of control)
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
October 1, 2008
October 1, 2008
Quality control lecture CPath master 2014 Ain Shams
 When you're running 2 or 4 control levels, use
the rules:
13s/22s/R4s/41s/10x
 When you're running 3 control levels, use a set
that works for multiples of threes:
13s/2of32s/R4s/ 31s/12x
 Rejection rule = Out of control=
1. Stop testing
2. Identify and correct problem
3. Repeat testing on pt samples and control
4. Don’t report pt results until problem is
solved and controls indicate proper
performance
 Change one variable at a time to troubleshoot an out of control
test.
 The variables are usually common to all instruments or
procedure systems and include the following:
 1. Try a fresh vial of QC
 2. Try a new reagent (same lot)
 3. Try a new consumable (water, part, solution, tubing) if
applicable.
 4. Try a new reagent (new lot)
 5. Recalibrate (current calibrator)
 6. Recalibrate (new lot calibrator)
 If a system cannot be brought into control, notify
senior staff. Do not process patient samples for the
test affected.
When changing to a new lot number of control material,
ideally there should be an overlap period while the new
material is being analyzed to establish the new control
limits.
In cases where the overlap period is not sufficient, it is
possible to establish the mean value for the new control
material in a short time, over say a five-day period, or to
start with the manufacturer’s values.
Then apply the previous estimate of SD to establish the
control limits.
These control limits should be temporary, until sufficient
data is collected to provide good estimates of both the
mean and SD of the new material.
 New lots of a quality control material should be
analyzed for each analyte in parallel with the lot of
control material in current use.
 Ideally, a minimum of at least 20 measurements should
be made on separate days when the measurement
system is known to be stable, based on QC results
from existing lots.
 If the desired 20 data points from 20 days are not
available, provisional values may have to be
established from data collected over fewer than 20
days.
 Possible approaches include making no more than four
control measurements per day for five different days
 Retained patients samples
◦ Original samples must be assayed in the lab under accepted control run
conditions
◦ Stored aliquited immediately after finishing 1st
analysis
◦ Storage conditions must meet the requirements for analytes to be
measured
◦ Avoid repeated warming/ thawing
◦ Stability of the measurand must be carefully respected
◦ Better to be alternating with QC material
◦ Result of the 1st
assay is used as the base for comparison and calculation
(as if gold value)
◦ Allowable analytical imprecision is used for judgment of acceptance or
rejection
◦ Data calculated from biological variations/ CLIA limits are used for the
issue
 Result comparison with an in-control method/
instrument/ procedure for the measurand
◦ The in-control instrument/ method is considered the
reference one
◦ Not more than one hour time gap between the parallel
assays
◦ Principles of assays must be considered if different
◦ Inaccuracy limits is used for comparison
◦ Data calculated from biological variations/ CLIA limits
are used for the issue
 Individual Patient Results:
◦ Clinical Correlations
◦ Correlation with other laboratory tests
◦ Intralaboratory duplicates
◦ Delta check with previous test results
◦ Limit Check
 Multiple Patients:
◦ Test distribution statistics
◦ Monitoring patients means
QUESTIONS
External Quality Control
Inter-laboratory comparisons and other
performance evaluations that may extend
throughout all phases of the testing cycle,
including interpretation of results; determination
of individual and collective laboratory
performance characteristics of examination
procedures by means of interlaboratory
comparison
A program in which multiple samples are
periodically sent to members of a group of
laboratories for analysis and/or identification, in
which each laboratory’s results are compared with
those of other laboratories in the group and/or with
an assigned value, and reported to the
participating laboratory and others
 Introduced into laboratory medicine more than 60
years ago to address that results for aliquots of the
same sample were different when measured by
different laboratories.
 PT/EQA programs are now an essential component of
a laboratory’s quality management system.
 PT/EQA is a component of laboratory accreditation
requirements
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
 Ideal samples for a PT/EQA program would fulfill a range of
criteria:
◦ Stable for the conditions under which they will be transported and
stored
◦ Homogeneous across all the aliquots produced
◦ Have analyte concentrations that include the expected clinical range
◦ Include appropriate sample types (e.g., urine, whole blood, serum)
◦ Available in sufficient volume
◦ Inexpensive enough for cost not to be an impediment
◦ Behave in clinical laboratory measurement procedures in
◦ the same manner as patient samples
◦ Samples from a single donor or pooled samples from multiple donors
can be used
 Samples have traceable reference values (when
reference values are used)
 Behave like patient samples (commutability)
 The laboratory may also consider cost
 Similarity of PT samples to patient samples
 Method compatibility with peer groups
 Size of peer groups
 Frequency of challenges
 Timeliness and usefulness of reports
 Educational content
 Customer service
Quality control lecture CPath master 2014 Ain Shams
 category 1 programs are limited because of:
• Technical aspects such as a lack of reference measurement
procedures, absence of certified reference materials, inability to prepare
commutable samples;
• Practical considerations such as the difficulty of preparing samples
covering the full measuring interval and the complicated logistics of
preparation and distribution of fresh or frozen samples;
• Psychological limitations such as lack of awareness of the quality
factors important in PT/EQA or unwillingness to adopt these;
• Economic concerns because distributing commutable samples in
sufficient quantity and providing target values with reference
measurement procedures is expensive
 PT samples should be tested in the same manner as
patient samples, to the extent possible
 Some laboratories may improperly test PT samples
differently from patient samples, by repeat testing of PT
samples when patient samples are tested only once, or by
having a specific analyst test PT samples rather than
rotating PT testing among all the personnel who perform
patient testing.
 There should be no attempt to produce “best” results by
replicate analysis or testing immediately following internal
QC or recalibration
 The core content of the result report should
resemble as closely as possible the content of a
routine clinical result report
 If the usual report is deemed inappropriate for a
PT report, it may equally be inappropriate for a
clinical report
 A copy of all PT reports should be retained within
the laboratory in order to verify the information
handling by the PT provider.
 Sending a set of samples from an organizing body to a group of
participating laboratories for measurement of 1 or more analytes present in
the samples
 Samples are intended to simulate the clinical samples usually measured
 Laboratories are not informed of the analyte concentration or activity in a
particular sample
 Timely schedules for running and reporting results are included
 Laboratory perform measurements in the same manner as for patient
samples
 Results for the samples are returned to the PT/EQA organizer for
evaluation of conformance to the expected results
 The organizer prepares a report that includes:
◦ the results reported by a laboratory
◦ the method used for the measurements
◦ the target values expected for each analyte
◦ evaluation of whether the individual laboratory’s results met the
performance requirements
◦ Reports may also include evaluation of the performance of the
various measurement procedures used by the participants
 The laboratory evaluates its performance according to
the provider report
 Limits or quality standards around the target value are established against
which performance can be assessed by:
◦ Regulatory: wider like US CLIA, German Rili-BAeK
◦ Statistical: ± 2-3 SD
◦ Clinically-based: on a difference that may affect clinical decisions or on biological
variation
 Total error limits including bias, imprecision, and analytical nonspecificity
can contribute to the variation in a single result
 Have different limits to separately assess bias and imprecision when replicate
samples are included
 PT/EQA limits are set as a minimum standard to identify results that indicate
poor performance. Thus, meeting these standards may not indicate that
performance is optimal nor that performance meets all clinical needs
 Determines the accuracy by comparing PT/EQA results to those
from a reference measurement procedure or from a designated
comparison method or to an all-participant (or all-method) mean/
median. This arrangement is now referred to as accuracy-based
evaluation
 Assess agreement with other measurement procedures and
imprecision among all methods as well as within a method group
 Peer group evaluation provides valuable information to assess
quality, verifying that a laboratory is using a measurement
procedure in conformance to the manufacturer’s specifications
and to other laboratories using the same technology
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
 PT/EQA result represents 1 point in time and will
occasionally be a random error
 Repeat the measurement using a stored aliquot of the
PT/EQA sample (assuming the measurand was stable
on storage) to confirm if the problem has persisted or
to conclude that the problem no longer exists and the
original unacceptable result was a random event, and
therefore no corrective action is indicated. If the
repeated result is still unacceptable, the laboratory
conducts further investigation to identify the root
cause, and then initiates corrective action
• Gather data related to the testing event to include
records of calibration, reagent use, QC results, and
maintenance procedures;
• Obtain other data on assay performance, e.g.,
previous PT/EQA results and relevant patient data;
• Identify the root cause of the error;
• Take corrective action and preventive action if
indicated;
• Monitor the success of the corrective action;
• Document the investigation and the corrective action.
• Was the testing material received in satisfactory condition?
• Was the appropriate sample tested?
• Were procedures for sample preparation followed?
• Was the appropriate method used for analysis?
• Was the method performed according to documented
procedures?
• Were appropriate reagents and controls used?
• Was equipment operated according to documented
procedures?
• Was equipment appropriately maintained?
• Was QC acceptable at the time of testing PT samples?
• Were results interpreted appropriately?
• Has this problem occurred previously with PT samples?
Are data consistent with previous PT distributions? Is
there a trend leading to failure or is the current set
completely unexpected?
• Did repeat testing on the properly stored residual sample
produce similar results?
• Were patient results acceptable at the time of PT testing?
1. Clerical error;
2. Methodologic problem;
3. Equipment problem;
4. Technical problem;
5. Problem with proficiency testing materials;
6. Problem with evaluation of results; and
7. No explanation after investigation: An investigation fails
to reveal an explanation for an unacceptable PT result 19 to 24% of the
time
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
 Split-Sample With Another Laboratory
 Internal Split-Sample Procedures
 Audit-Sample Procedure
 Analysis of Manufacturer’s Product Calibrator or
Trueness Control Material
 Analysis of Interlaboratory Quality Control Data
 Averages of Patient Data
 Reference Intervals
 Reevaluation of Interpreted Results
 Direct Observation of Technique-Dependent Tests
 Clinical Correlation Studies
 Government and University Interlaboratory Comparison
Programs
 Analysis of Data From Qualitative Alternative
Assessment Procedures
YOUR VALUABLE QUESTIONS

Weitere ähnliche Inhalte

Was ist angesagt?

Internal quality control in clinical laboratories hematology(2)
Internal quality control in clinical laboratories hematology(2)Internal quality control in clinical laboratories hematology(2)
Internal quality control in clinical laboratories hematology(2)NAZAR ABU-DULLA
 
Quality control in clinical laboratory
Quality control in clinical laboratoryQuality control in clinical laboratory
Quality control in clinical laboratorydrgomi basar
 
quality control in clinical laboratory
quality control in clinical laboratory quality control in clinical laboratory
quality control in clinical laboratory DrmanarEmam
 
Quality Control in Pathological Laboratory
Quality Control in Pathological LaboratoryQuality Control in Pathological Laboratory
Quality Control in Pathological Laboratorysanarehman8159
 
Quality control in clinical laboratories
Quality control in clinical laboratoriesQuality control in clinical laboratories
Quality control in clinical laboratoriesAshish Jawarkar
 
Troubleshooting Poor EQA/QC Performance in the Laboratory
Troubleshooting Poor EQA/QC Performance in the Laboratory Troubleshooting Poor EQA/QC Performance in the Laboratory
Troubleshooting Poor EQA/QC Performance in the Laboratory Randox
 
Quality assurance in the department of clinical biochemistry
Quality assurance in the department of clinical biochemistryQuality assurance in the department of clinical biochemistry
Quality assurance in the department of clinical biochemistryDipesh Tamrakar
 
Quality Management System
Quality Management System Quality Management System
Quality Management System Prasenjit Mitra
 
Troubleshooting QC Problems: Your QC has failed, what do you do next?
Troubleshooting QC Problems: Your QC has failed, what do you do next?Troubleshooting QC Problems: Your QC has failed, what do you do next?
Troubleshooting QC Problems: Your QC has failed, what do you do next?Randox
 
Quality control
Quality controlQuality control
Quality controlSKYFALL
 
ISO 15189 Accreditation Guide - Improving Laboratory Performance Through Qual...
ISO 15189 Accreditation Guide - Improving Laboratory Performance Through Qual...ISO 15189 Accreditation Guide - Improving Laboratory Performance Through Qual...
ISO 15189 Accreditation Guide - Improving Laboratory Performance Through Qual...Randox
 

Was ist angesagt? (20)

Quality control
Quality controlQuality control
Quality control
 
Medical Laboratory Quality Assurance
Medical Laboratory Quality AssuranceMedical Laboratory Quality Assurance
Medical Laboratory Quality Assurance
 
Laboratory accreditation by iso 15189
Laboratory accreditation by iso 15189Laboratory accreditation by iso 15189
Laboratory accreditation by iso 15189
 
Internal quality control in clinical laboratories hematology(2)
Internal quality control in clinical laboratories hematology(2)Internal quality control in clinical laboratories hematology(2)
Internal quality control in clinical laboratories hematology(2)
 
Quality control in clinical laboratory
Quality control in clinical laboratoryQuality control in clinical laboratory
Quality control in clinical laboratory
 
Quality Control for Medical Laboratories
Quality Control for Medical LaboratoriesQuality Control for Medical Laboratories
Quality Control for Medical Laboratories
 
Quality assurance in a medical laboratory
Quality assurance in a medical laboratoryQuality assurance in a medical laboratory
Quality assurance in a medical laboratory
 
quality control in clinical laboratory
quality control in clinical laboratory quality control in clinical laboratory
quality control in clinical laboratory
 
Quality Control in Pathological Laboratory
Quality Control in Pathological LaboratoryQuality Control in Pathological Laboratory
Quality Control in Pathological Laboratory
 
Quality control in clinical laboratories
Quality control in clinical laboratoriesQuality control in clinical laboratories
Quality control in clinical laboratories
 
Troubleshooting Poor EQA/QC Performance in the Laboratory
Troubleshooting Poor EQA/QC Performance in the Laboratory Troubleshooting Poor EQA/QC Performance in the Laboratory
Troubleshooting Poor EQA/QC Performance in the Laboratory
 
Quality assurance in the department of clinical biochemistry
Quality assurance in the department of clinical biochemistryQuality assurance in the department of clinical biochemistry
Quality assurance in the department of clinical biochemistry
 
Quality Management System
Quality Management System Quality Management System
Quality Management System
 
Troubleshooting IQC / EQAS
Troubleshooting IQC / EQASTroubleshooting IQC / EQAS
Troubleshooting IQC / EQAS
 
Troubleshooting QC Problems: Your QC has failed, what do you do next?
Troubleshooting QC Problems: Your QC has failed, what do you do next?Troubleshooting QC Problems: Your QC has failed, what do you do next?
Troubleshooting QC Problems: Your QC has failed, what do you do next?
 
Quality control
Quality controlQuality control
Quality control
 
Quality assurance
Quality assuranceQuality assurance
Quality assurance
 
Troubleshooting iqc eqas 19.07.2018
Troubleshooting iqc eqas 19.07.2018Troubleshooting iqc eqas 19.07.2018
Troubleshooting iqc eqas 19.07.2018
 
ISO 15189 Accreditation Guide - Improving Laboratory Performance Through Qual...
ISO 15189 Accreditation Guide - Improving Laboratory Performance Through Qual...ISO 15189 Accreditation Guide - Improving Laboratory Performance Through Qual...
ISO 15189 Accreditation Guide - Improving Laboratory Performance Through Qual...
 
Lab management
Lab managementLab management
Lab management
 

Andere mochten auch

Plagiarism Power Point
Plagiarism Power PointPlagiarism Power Point
Plagiarism Power Pointgoodfriday
 
plagiarism detection tools and techniques
plagiarism detection tools and techniquesplagiarism detection tools and techniques
plagiarism detection tools and techniquesNimisha T
 
Plagiarism PowerPoint Presentation
Plagiarism PowerPoint PresentationPlagiarism PowerPoint Presentation
Plagiarism PowerPoint PresentationSteve Nelson
 
Plagiarism Ppt Teachers
Plagiarism Ppt TeachersPlagiarism Ppt Teachers
Plagiarism Ppt TeachersTedine Soule
 
Quality control laboratory.
Quality control laboratory.Quality control laboratory.
Quality control laboratory.heli1992
 

Andere mochten auch (6)

Plagiarism Power Point
Plagiarism Power PointPlagiarism Power Point
Plagiarism Power Point
 
plagiarism detection tools and techniques
plagiarism detection tools and techniquesplagiarism detection tools and techniques
plagiarism detection tools and techniques
 
Plagiarism Powerpoint
Plagiarism PowerpointPlagiarism Powerpoint
Plagiarism Powerpoint
 
Plagiarism PowerPoint Presentation
Plagiarism PowerPoint PresentationPlagiarism PowerPoint Presentation
Plagiarism PowerPoint Presentation
 
Plagiarism Ppt Teachers
Plagiarism Ppt TeachersPlagiarism Ppt Teachers
Plagiarism Ppt Teachers
 
Quality control laboratory.
Quality control laboratory.Quality control laboratory.
Quality control laboratory.
 

Ähnlich wie Quality control lecture CPath master 2014 Ain Shams

Types of validation & validation of specific dosage.pptx
Types of validation & validation of specific dosage.pptxTypes of validation & validation of specific dosage.pptx
Types of validation & validation of specific dosage.pptxankitanakashe21
 
Laboratory Quality Control .ppt
Laboratory Quality Control .pptLaboratory Quality Control .ppt
Laboratory Quality Control .pptABRARAHMED767665
 
lect 7 quality control quant tests slides.pdf
lect 7 quality control quant tests slides.pdflect 7 quality control quant tests slides.pdf
lect 7 quality control quant tests slides.pdfmariammansour18
 
lect 7 quality control quant tests slides.pdf
lect 7 quality control quant tests slides.pdflect 7 quality control quant tests slides.pdf
lect 7 quality control quant tests slides.pdfmariammansour18
 
PHARMACEUTICAL VALIDATION
 PHARMACEUTICAL  VALIDATION PHARMACEUTICAL  VALIDATION
PHARMACEUTICAL VALIDATIONSACHIN C P
 
Quality control in a virology laboratory.pdf
Quality control in a virology laboratory.pdfQuality control in a virology laboratory.pdf
Quality control in a virology laboratory.pdfsamwel18
 
bio statistical tools of process validation
bio statistical tools of process validationbio statistical tools of process validation
bio statistical tools of process validationmounika chowdary
 
Pharmaceutical validation QA I Year.pptx
Pharmaceutical validation QA I Year.pptxPharmaceutical validation QA I Year.pptx
Pharmaceutical validation QA I Year.pptxmanoharkasde123
 
Pharmaceutical validation
Pharmaceutical  validationPharmaceutical  validation
Pharmaceutical validationPavisara
 
Share_Total_Quality_Management.pptx
Share_Total_Quality_Management.pptxShare_Total_Quality_Management.pptx
Share_Total_Quality_Management.pptxRiyaKaushal21ZO042
 
Basic concept of process validation
Basic concept of process validation Basic concept of process validation
Basic concept of process validation Bishnu Koirala
 
Understanding statistics in laboratory quality control
Understanding statistics in laboratory quality controlUnderstanding statistics in laboratory quality control
Understanding statistics in laboratory quality controlRandox
 
Validation of lab instruments and quantitative test methods
Validation of lab instruments and quantitative test methods Validation of lab instruments and quantitative test methods
Validation of lab instruments and quantitative test methods Mostafa Mahmoud
 
ANALYTICAL VARIABLES IN QUALITY CONTROL.pptx
ANALYTICAL VARIABLES IN QUALITY CONTROL.pptxANALYTICAL VARIABLES IN QUALITY CONTROL.pptx
ANALYTICAL VARIABLES IN QUALITY CONTROL.pptxDr. Jagroop Singh
 
QUALITY SYSTEMS
QUALITY SYSTEMS QUALITY SYSTEMS
QUALITY SYSTEMS MSURUTHI1
 
Qualification of Dissolution Test Apparatus and Validation of Utility System
Qualification of Dissolution Test Apparatus and Validation of Utility SystemQualification of Dissolution Test Apparatus and Validation of Utility System
Qualification of Dissolution Test Apparatus and Validation of Utility SystemAkshay Trivedi , Maliba Pharmacy College
 
calibration-and-validation
calibration-and-validationcalibration-and-validation
calibration-and-validationSUJITHA MARY
 
Seminar on validation by ranjeet singh
Seminar on validation by ranjeet singhSeminar on validation by ranjeet singh
Seminar on validation by ranjeet singhRanjeet Singh
 

Ähnlich wie Quality control lecture CPath master 2014 Ain Shams (20)

Types of validation & validation of specific dosage.pptx
Types of validation & validation of specific dosage.pptxTypes of validation & validation of specific dosage.pptx
Types of validation & validation of specific dosage.pptx
 
Laboratory Quality Control .ppt
Laboratory Quality Control .pptLaboratory Quality Control .ppt
Laboratory Quality Control .ppt
 
Vallidation
VallidationVallidation
Vallidation
 
lect 7 quality control quant tests slides.pdf
lect 7 quality control quant tests slides.pdflect 7 quality control quant tests slides.pdf
lect 7 quality control quant tests slides.pdf
 
lect 7 quality control quant tests slides.pdf
lect 7 quality control quant tests slides.pdflect 7 quality control quant tests slides.pdf
lect 7 quality control quant tests slides.pdf
 
PHARMACEUTICAL VALIDATION
 PHARMACEUTICAL  VALIDATION PHARMACEUTICAL  VALIDATION
PHARMACEUTICAL VALIDATION
 
Quality control in a virology laboratory.pdf
Quality control in a virology laboratory.pdfQuality control in a virology laboratory.pdf
Quality control in a virology laboratory.pdf
 
bio statistical tools of process validation
bio statistical tools of process validationbio statistical tools of process validation
bio statistical tools of process validation
 
Pharmaceutical validation QA I Year.pptx
Pharmaceutical validation QA I Year.pptxPharmaceutical validation QA I Year.pptx
Pharmaceutical validation QA I Year.pptx
 
Pharmaceutical validation
Pharmaceutical  validationPharmaceutical  validation
Pharmaceutical validation
 
Share_Total_Quality_Management.pptx
Share_Total_Quality_Management.pptxShare_Total_Quality_Management.pptx
Share_Total_Quality_Management.pptx
 
Basic concept of process validation
Basic concept of process validation Basic concept of process validation
Basic concept of process validation
 
Understanding statistics in laboratory quality control
Understanding statistics in laboratory quality controlUnderstanding statistics in laboratory quality control
Understanding statistics in laboratory quality control
 
Validation of lab instruments and quantitative test methods
Validation of lab instruments and quantitative test methods Validation of lab instruments and quantitative test methods
Validation of lab instruments and quantitative test methods
 
ANALYTICAL VARIABLES IN QUALITY CONTROL.pptx
ANALYTICAL VARIABLES IN QUALITY CONTROL.pptxANALYTICAL VARIABLES IN QUALITY CONTROL.pptx
ANALYTICAL VARIABLES IN QUALITY CONTROL.pptx
 
QUALITY SYSTEMS
QUALITY SYSTEMS QUALITY SYSTEMS
QUALITY SYSTEMS
 
Calibration
CalibrationCalibration
Calibration
 
Qualification of Dissolution Test Apparatus and Validation of Utility System
Qualification of Dissolution Test Apparatus and Validation of Utility SystemQualification of Dissolution Test Apparatus and Validation of Utility System
Qualification of Dissolution Test Apparatus and Validation of Utility System
 
calibration-and-validation
calibration-and-validationcalibration-and-validation
calibration-and-validation
 
Seminar on validation by ranjeet singh
Seminar on validation by ranjeet singhSeminar on validation by ranjeet singh
Seminar on validation by ranjeet singh
 

Kürzlich hochgeladen

Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.EnglishCEIPdeSigeiro
 
EBUS5423 Data Analytics and Reporting Bl
EBUS5423 Data Analytics and Reporting BlEBUS5423 Data Analytics and Reporting Bl
EBUS5423 Data Analytics and Reporting BlDr. Bruce A. Johnson
 
Education and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxEducation and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxraviapr7
 
CapTechU Doctoral Presentation -March 2024 slides.pptx
CapTechU Doctoral Presentation -March 2024 slides.pptxCapTechU Doctoral Presentation -March 2024 slides.pptx
CapTechU Doctoral Presentation -March 2024 slides.pptxCapitolTechU
 
Slides CapTechTalks Webinar March 2024 Joshua Sinai.pptx
Slides CapTechTalks Webinar March 2024 Joshua Sinai.pptxSlides CapTechTalks Webinar March 2024 Joshua Sinai.pptx
Slides CapTechTalks Webinar March 2024 Joshua Sinai.pptxCapitolTechU
 
A gentle introduction to Artificial Intelligence
A gentle introduction to Artificial IntelligenceA gentle introduction to Artificial Intelligence
A gentle introduction to Artificial IntelligenceApostolos Syropoulos
 
How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17Celine George
 
3.21.24 The Origins of Black Power.pptx
3.21.24  The Origins of Black Power.pptx3.21.24  The Origins of Black Power.pptx
3.21.24 The Origins of Black Power.pptxmary850239
 
HED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfHED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfMohonDas
 
SOLIDE WASTE in Cameroon,,,,,,,,,,,,,,,,,,,,,,,,,,,.pptx
SOLIDE WASTE in Cameroon,,,,,,,,,,,,,,,,,,,,,,,,,,,.pptxSOLIDE WASTE in Cameroon,,,,,,,,,,,,,,,,,,,,,,,,,,,.pptx
SOLIDE WASTE in Cameroon,,,,,,,,,,,,,,,,,,,,,,,,,,,.pptxSyedNadeemGillANi
 
Diploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdfDiploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdfMohonDas
 
KARNAADA.pptx made by - saransh dwivedi ( SD ) - SHALAKYA TANTRA - ENT - 4...
KARNAADA.pptx  made by -  saransh dwivedi ( SD ) -  SHALAKYA TANTRA - ENT - 4...KARNAADA.pptx  made by -  saransh dwivedi ( SD ) -  SHALAKYA TANTRA - ENT - 4...
KARNAADA.pptx made by - saransh dwivedi ( SD ) - SHALAKYA TANTRA - ENT - 4...M56BOOKSTORE PRODUCT/SERVICE
 
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfP4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfYu Kanazawa / Osaka University
 
10 Topics For MBA Project Report [HR].pdf
10 Topics For MBA Project Report [HR].pdf10 Topics For MBA Project Report [HR].pdf
10 Topics For MBA Project Report [HR].pdfJayanti Pande
 
Optical Fibre and It's Applications.pptx
Optical Fibre and It's Applications.pptxOptical Fibre and It's Applications.pptx
Optical Fibre and It's Applications.pptxPurva Nikam
 
Ultra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptxUltra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptxDr. Asif Anas
 
How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17Celine George
 
Protein Structure - threading Protein modelling pptx
Protein Structure - threading Protein modelling pptxProtein Structure - threading Protein modelling pptx
Protein Structure - threading Protein modelling pptxvidhisharma994099
 

Kürzlich hochgeladen (20)

March 2024 Directors Meeting, Division of Student Affairs and Academic Support
March 2024 Directors Meeting, Division of Student Affairs and Academic SupportMarch 2024 Directors Meeting, Division of Student Affairs and Academic Support
March 2024 Directors Meeting, Division of Student Affairs and Academic Support
 
Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.
 
EBUS5423 Data Analytics and Reporting Bl
EBUS5423 Data Analytics and Reporting BlEBUS5423 Data Analytics and Reporting Bl
EBUS5423 Data Analytics and Reporting Bl
 
Prelims of Kant get Marx 2.0: a general politics quiz
Prelims of Kant get Marx 2.0: a general politics quizPrelims of Kant get Marx 2.0: a general politics quiz
Prelims of Kant get Marx 2.0: a general politics quiz
 
Education and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxEducation and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptx
 
CapTechU Doctoral Presentation -March 2024 slides.pptx
CapTechU Doctoral Presentation -March 2024 slides.pptxCapTechU Doctoral Presentation -March 2024 slides.pptx
CapTechU Doctoral Presentation -March 2024 slides.pptx
 
Slides CapTechTalks Webinar March 2024 Joshua Sinai.pptx
Slides CapTechTalks Webinar March 2024 Joshua Sinai.pptxSlides CapTechTalks Webinar March 2024 Joshua Sinai.pptx
Slides CapTechTalks Webinar March 2024 Joshua Sinai.pptx
 
A gentle introduction to Artificial Intelligence
A gentle introduction to Artificial IntelligenceA gentle introduction to Artificial Intelligence
A gentle introduction to Artificial Intelligence
 
How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17
 
3.21.24 The Origins of Black Power.pptx
3.21.24  The Origins of Black Power.pptx3.21.24  The Origins of Black Power.pptx
3.21.24 The Origins of Black Power.pptx
 
HED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfHED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdf
 
SOLIDE WASTE in Cameroon,,,,,,,,,,,,,,,,,,,,,,,,,,,.pptx
SOLIDE WASTE in Cameroon,,,,,,,,,,,,,,,,,,,,,,,,,,,.pptxSOLIDE WASTE in Cameroon,,,,,,,,,,,,,,,,,,,,,,,,,,,.pptx
SOLIDE WASTE in Cameroon,,,,,,,,,,,,,,,,,,,,,,,,,,,.pptx
 
Diploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdfDiploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdf
 
KARNAADA.pptx made by - saransh dwivedi ( SD ) - SHALAKYA TANTRA - ENT - 4...
KARNAADA.pptx  made by -  saransh dwivedi ( SD ) -  SHALAKYA TANTRA - ENT - 4...KARNAADA.pptx  made by -  saransh dwivedi ( SD ) -  SHALAKYA TANTRA - ENT - 4...
KARNAADA.pptx made by - saransh dwivedi ( SD ) - SHALAKYA TANTRA - ENT - 4...
 
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfP4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
 
10 Topics For MBA Project Report [HR].pdf
10 Topics For MBA Project Report [HR].pdf10 Topics For MBA Project Report [HR].pdf
10 Topics For MBA Project Report [HR].pdf
 
Optical Fibre and It's Applications.pptx
Optical Fibre and It's Applications.pptxOptical Fibre and It's Applications.pptx
Optical Fibre and It's Applications.pptx
 
Ultra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptxUltra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptx
 
How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17
 
Protein Structure - threading Protein modelling pptx
Protein Structure - threading Protein modelling pptxProtein Structure - threading Protein modelling pptx
Protein Structure - threading Protein modelling pptx
 

Quality control lecture CPath master 2014 Ain Shams

  • 3.  All management systems are focused on getting the job done.  More efficient and effective management guarantees the job to be done in the proper way. Larger profit Better serviceVs
  • 4. STAGE ACTIVITIES PERFORMED 1. TOTAL QUALITY MANAGEMENT Management approach centered around “Customer Satisfaction” 2. QUALITY MANAGEMENT All of the below plus the economic aspects of “Cost of Quality” 3. QUALITY SYSTEM “Comprehensive and Coordinated” efforts to meet quality objectives 4. QUALITY ASSURANCE Systematic activities to provide “Confidence” that the organization meets requirements for quality 5. QUALITY CONTROL Operational techniques applied to “Specific Tasks” for quality and regulatory compliance.
  • 6.  Quality : degree to which a set of inherent characteristics fulfills requirements  Quality control: part of quality management focused on fulfilling quality requirements  Quality assurance: part of quality management focused on providing confidence that quality requirements will be fulfilled  Quality management: coordinated activities to direct and control an organization with regard to quality
  • 7. 1942-521942-52 US Military develop requirements for contractors for shell, aircraft, missileUS Military develop requirements for contractors for shell, aircraft, missile supplierssuppliers (Quality without 100% inspection)(Quality without 100% inspection) 19471947 International Organization for Standardization (ISO)International Organization for Standardization (ISO) created to adopt industrialcreated to adopt industrial standardsstandards 19591959 US Department of Defense establishedUS Department of Defense established MIL-Q-9858MIL-Q-9858 quality managementquality management 19631963 MIL-Q-9858 is internationalized as anMIL-Q-9858 is internationalized as an ABCAABCA standardstandard 19681968 NATO adopts MIL-Q-9858A as Allied Quality Assurance Publication 1 (NATO adopts MIL-Q-9858A as Allied Quality Assurance Publication 1 (AQAP-1AQAP-1)) 19791979 British Standards Institute (BSI) developed AQAP-1 for civilian useBritish Standards Institute (BSI) developed AQAP-1 for civilian use BS 5750BS 5750
  • 8.  Calibration: the process of testing and adjustment of an instrument, kit, or test system to provide a known relationship between the measurement response and the value of the substance measured by the test procedure  Effectiveness: the extent to which planned activities are realized and planned results achieved  Efficiency: the relationship between the results achieved and the resources used
  • 9.  Non-QMS processes – processes that are not contained in either the QSEs or in the laboratory’s path of workflow, such as those within the finance, sales, or marketing functions.  Path of workflow: the sequential processes in a laboratory’s activities that transform a request for examination into the laboratory information that is captured in the report of results.  Plan: written account of intended future course of actions aimed at achieving specific goal(s) or objective(s) within a specific timeframe and explains in detail what needs to be done, when, how, and by whom.
  • 11.   Organization Customer Focus Facilities and Safety Personnel Purchasing and Inventory Equipment Process Management  Pre-examination Examination Post-examination Documents and Records Information Management Nonconforming Event Management Assessments Continual Improvement Pree-xamination Examination Post-examination Information Management  Quality System Essentials - those elements which must be applied to all operations in the service’s path of workflow  Path of Workflow - as it relates to the processes involved in the pre-, during and post- phases of delivery of services with the laboratory as an example
  • 16. ! Internal Quality Control (IQC) Procedures ! External Quality Assessment (EQA) ! Quality Management
  • 18. ⇒ Done during daily routine work ⇒ Provides an immediate control ⇒ Errors are corrected immediately ⇒ Routinely collect and analyze data from every test run or procedure Why do we need Internal Quality Control? ! Ensure that test results are reliable (trustable) ! Ensure that test results are reproducible (Closeness of the results of assays of the same test carried under changed conditions) ! Control quality of daily routine work
  • 19. Monitoring quality of laboratory testing, accuracy and precision of laboratory results
  • 20.  Precise and Inaccurate  Precise and Accurate
  • 21.  Imprecise and Inaccurate  Imprecise and ?? Accurate
  • 22.  It ensures continual check that the laboratory’s work does not fluctuate and that reports are validated before they are released.  It is based on monitoring the procedures which are actually used for the tests in the laboratory. It includes: · Control charts with tests on control materials · Duplicate tests on all specimens or on a proportion of the specimens · Delta check, comparing current test results with previous results · Consistency of mean values of patient data
  • 23.  Use 2-3 levels of controls covering the medical decision points  At least 20 control values over a period of 20-30 days for each level of control  Perform statistical analysis  Develop Levey-Jenning chart  Run -regularly- with patient samples  Monitor control values on chart using Westgard rules  Take immediate corrective action, if needed  Record actions taken (if any)
  • 24.  QC material must be available in large quantities stored in small aliquots (Ideally should last for at least 1 year)  Always consider as Biohazardous  Requires very accurate reconstitution if needed  Always deal with and store as recommended by manufacturer
  • 25.  Need data set of at least 20 points obtained over 20-30 days better by different operators in different times of day  Calculate mean, standard deviation, Coefficient of variation and determine target ranges  Develop Levey-Jenning charts  Plot –on the chart- control values each run/ day  Make decisions regarding acceptability of run using Westgard rules  Monitor over time and at defined intervals
  • 26. 1. 192 mg/dL 2. 194 mg/dL 3. 196 mg/dL 4. 196 mg/dL 5. 160 mg/dL 6. 196 mg/dL 7. 200 mg/dL 8. 200 mg/dL 9. 202 mg/dL 10. 255 mg/dL 11. 204 mg/dL 12. 208 mg/dL 13. 212 mg/dL
  • 27. 80 85 90 95 100 105 110 115 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Day Mean +1SD +2SD +3SD -1SD -2SD -3SD
  • 28. 80 85 90 95 100 105 110 115 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Day Mean +1SD +2SD +3SD -1SD -2SD -3SD
  • 30.  Ideally should have control values clustered around the mean (+/-2 SD) with little variation in the upward or downward direction  Imprecision = large amount of scatter around the mean. Usually caused by errors in technique  Inaccuracy = may see as a trend or a shift, usually caused by change in the testing process  Random error = no pattern. Usually poor technique, malfunctioning equipment
  • 31. Random Error (RE): Imprecision  Causes: 1. Pipetting error 2. Temperature error 3. Mixing defect 4. Machine need troubleshooting  Systematic Error (SE): Inaccuracy  Causes: 1. Deterioration of control material 2. Deterioration of calibrator 3. Deterioration of reagents
  • 32.  Allows determination of whether an analytical run/s (in control) or (out of control)
  • 49.  When you're running 2 or 4 control levels, use the rules: 13s/22s/R4s/41s/10x  When you're running 3 control levels, use a set that works for multiples of threes: 13s/2of32s/R4s/ 31s/12x
  • 50.  Rejection rule = Out of control= 1. Stop testing 2. Identify and correct problem 3. Repeat testing on pt samples and control 4. Don’t report pt results until problem is solved and controls indicate proper performance
  • 51.  Change one variable at a time to troubleshoot an out of control test.  The variables are usually common to all instruments or procedure systems and include the following:  1. Try a fresh vial of QC  2. Try a new reagent (same lot)  3. Try a new consumable (water, part, solution, tubing) if applicable.  4. Try a new reagent (new lot)  5. Recalibrate (current calibrator)  6. Recalibrate (new lot calibrator)  If a system cannot be brought into control, notify senior staff. Do not process patient samples for the test affected.
  • 52. When changing to a new lot number of control material, ideally there should be an overlap period while the new material is being analyzed to establish the new control limits. In cases where the overlap period is not sufficient, it is possible to establish the mean value for the new control material in a short time, over say a five-day period, or to start with the manufacturer’s values. Then apply the previous estimate of SD to establish the control limits. These control limits should be temporary, until sufficient data is collected to provide good estimates of both the mean and SD of the new material.
  • 53.  New lots of a quality control material should be analyzed for each analyte in parallel with the lot of control material in current use.  Ideally, a minimum of at least 20 measurements should be made on separate days when the measurement system is known to be stable, based on QC results from existing lots.  If the desired 20 data points from 20 days are not available, provisional values may have to be established from data collected over fewer than 20 days.  Possible approaches include making no more than four control measurements per day for five different days
  • 54.  Retained patients samples ◦ Original samples must be assayed in the lab under accepted control run conditions ◦ Stored aliquited immediately after finishing 1st analysis ◦ Storage conditions must meet the requirements for analytes to be measured ◦ Avoid repeated warming/ thawing ◦ Stability of the measurand must be carefully respected ◦ Better to be alternating with QC material ◦ Result of the 1st assay is used as the base for comparison and calculation (as if gold value) ◦ Allowable analytical imprecision is used for judgment of acceptance or rejection ◦ Data calculated from biological variations/ CLIA limits are used for the issue
  • 55.  Result comparison with an in-control method/ instrument/ procedure for the measurand ◦ The in-control instrument/ method is considered the reference one ◦ Not more than one hour time gap between the parallel assays ◦ Principles of assays must be considered if different ◦ Inaccuracy limits is used for comparison ◦ Data calculated from biological variations/ CLIA limits are used for the issue
  • 56.  Individual Patient Results: ◦ Clinical Correlations ◦ Correlation with other laboratory tests ◦ Intralaboratory duplicates ◦ Delta check with previous test results ◦ Limit Check  Multiple Patients: ◦ Test distribution statistics ◦ Monitoring patients means
  • 59. Inter-laboratory comparisons and other performance evaluations that may extend throughout all phases of the testing cycle, including interpretation of results; determination of individual and collective laboratory performance characteristics of examination procedures by means of interlaboratory comparison
  • 60. A program in which multiple samples are periodically sent to members of a group of laboratories for analysis and/or identification, in which each laboratory’s results are compared with those of other laboratories in the group and/or with an assigned value, and reported to the participating laboratory and others
  • 61.  Introduced into laboratory medicine more than 60 years ago to address that results for aliquots of the same sample were different when measured by different laboratories.  PT/EQA programs are now an essential component of a laboratory’s quality management system.  PT/EQA is a component of laboratory accreditation requirements
  • 64.  Ideal samples for a PT/EQA program would fulfill a range of criteria: ◦ Stable for the conditions under which they will be transported and stored ◦ Homogeneous across all the aliquots produced ◦ Have analyte concentrations that include the expected clinical range ◦ Include appropriate sample types (e.g., urine, whole blood, serum) ◦ Available in sufficient volume ◦ Inexpensive enough for cost not to be an impediment ◦ Behave in clinical laboratory measurement procedures in ◦ the same manner as patient samples ◦ Samples from a single donor or pooled samples from multiple donors can be used
  • 65.  Samples have traceable reference values (when reference values are used)  Behave like patient samples (commutability)  The laboratory may also consider cost  Similarity of PT samples to patient samples  Method compatibility with peer groups  Size of peer groups  Frequency of challenges  Timeliness and usefulness of reports  Educational content  Customer service
  • 67.  category 1 programs are limited because of: • Technical aspects such as a lack of reference measurement procedures, absence of certified reference materials, inability to prepare commutable samples; • Practical considerations such as the difficulty of preparing samples covering the full measuring interval and the complicated logistics of preparation and distribution of fresh or frozen samples; • Psychological limitations such as lack of awareness of the quality factors important in PT/EQA or unwillingness to adopt these; • Economic concerns because distributing commutable samples in sufficient quantity and providing target values with reference measurement procedures is expensive
  • 68.  PT samples should be tested in the same manner as patient samples, to the extent possible  Some laboratories may improperly test PT samples differently from patient samples, by repeat testing of PT samples when patient samples are tested only once, or by having a specific analyst test PT samples rather than rotating PT testing among all the personnel who perform patient testing.  There should be no attempt to produce “best” results by replicate analysis or testing immediately following internal QC or recalibration
  • 69.  The core content of the result report should resemble as closely as possible the content of a routine clinical result report  If the usual report is deemed inappropriate for a PT report, it may equally be inappropriate for a clinical report  A copy of all PT reports should be retained within the laboratory in order to verify the information handling by the PT provider.
  • 70.  Sending a set of samples from an organizing body to a group of participating laboratories for measurement of 1 or more analytes present in the samples  Samples are intended to simulate the clinical samples usually measured  Laboratories are not informed of the analyte concentration or activity in a particular sample  Timely schedules for running and reporting results are included  Laboratory perform measurements in the same manner as for patient samples  Results for the samples are returned to the PT/EQA organizer for evaluation of conformance to the expected results
  • 71.  The organizer prepares a report that includes: ◦ the results reported by a laboratory ◦ the method used for the measurements ◦ the target values expected for each analyte ◦ evaluation of whether the individual laboratory’s results met the performance requirements ◦ Reports may also include evaluation of the performance of the various measurement procedures used by the participants  The laboratory evaluates its performance according to the provider report
  • 72.  Limits or quality standards around the target value are established against which performance can be assessed by: ◦ Regulatory: wider like US CLIA, German Rili-BAeK ◦ Statistical: ± 2-3 SD ◦ Clinically-based: on a difference that may affect clinical decisions or on biological variation  Total error limits including bias, imprecision, and analytical nonspecificity can contribute to the variation in a single result  Have different limits to separately assess bias and imprecision when replicate samples are included  PT/EQA limits are set as a minimum standard to identify results that indicate poor performance. Thus, meeting these standards may not indicate that performance is optimal nor that performance meets all clinical needs
  • 73.  Determines the accuracy by comparing PT/EQA results to those from a reference measurement procedure or from a designated comparison method or to an all-participant (or all-method) mean/ median. This arrangement is now referred to as accuracy-based evaluation  Assess agreement with other measurement procedures and imprecision among all methods as well as within a method group  Peer group evaluation provides valuable information to assess quality, verifying that a laboratory is using a measurement procedure in conformance to the manufacturer’s specifications and to other laboratories using the same technology
  • 84.  PT/EQA result represents 1 point in time and will occasionally be a random error  Repeat the measurement using a stored aliquot of the PT/EQA sample (assuming the measurand was stable on storage) to confirm if the problem has persisted or to conclude that the problem no longer exists and the original unacceptable result was a random event, and therefore no corrective action is indicated. If the repeated result is still unacceptable, the laboratory conducts further investigation to identify the root cause, and then initiates corrective action
  • 85. • Gather data related to the testing event to include records of calibration, reagent use, QC results, and maintenance procedures; • Obtain other data on assay performance, e.g., previous PT/EQA results and relevant patient data; • Identify the root cause of the error; • Take corrective action and preventive action if indicated; • Monitor the success of the corrective action; • Document the investigation and the corrective action.
  • 86. • Was the testing material received in satisfactory condition? • Was the appropriate sample tested? • Were procedures for sample preparation followed? • Was the appropriate method used for analysis? • Was the method performed according to documented procedures? • Were appropriate reagents and controls used? • Was equipment operated according to documented procedures?
  • 87. • Was equipment appropriately maintained? • Was QC acceptable at the time of testing PT samples? • Were results interpreted appropriately? • Has this problem occurred previously with PT samples? Are data consistent with previous PT distributions? Is there a trend leading to failure or is the current set completely unexpected? • Did repeat testing on the properly stored residual sample produce similar results? • Were patient results acceptable at the time of PT testing?
  • 88. 1. Clerical error; 2. Methodologic problem; 3. Equipment problem; 4. Technical problem; 5. Problem with proficiency testing materials; 6. Problem with evaluation of results; and 7. No explanation after investigation: An investigation fails to reveal an explanation for an unacceptable PT result 19 to 24% of the time
  • 93.  Split-Sample With Another Laboratory  Internal Split-Sample Procedures  Audit-Sample Procedure  Analysis of Manufacturer’s Product Calibrator or Trueness Control Material  Analysis of Interlaboratory Quality Control Data  Averages of Patient Data
  • 94.  Reference Intervals  Reevaluation of Interpreted Results  Direct Observation of Technique-Dependent Tests  Clinical Correlation Studies  Government and University Interlaboratory Comparison Programs  Analysis of Data From Qualitative Alternative Assessment Procedures